Intellectual Property India Publishes Patent Application for 'Alpha4 Beta7 Integrin Antagonists And Uses Thereof' Filed by Xinthera, Inc.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517067771 A) filed by Xinthera, Inc., Foster City, U.S.A., on July 16, for 'alpha4 beta7 integrin antagonists and uses thereof.'

Inventor(s) include Hoffman, Robert L; Pinchman, Joseph Robert; Va, Porino Jinjo; and Dong, Qing.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "Described herein are a47 integrin inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a47integrin-mediated conditions, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD)."

The patent application was internationally filed on Dec. 21, 2023, under International application No.PCT/US2023/085522.

Disclaimer: Curated by HT Syndication.